What is the treatment (Tx) for alcohol withdrawal?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Alcohol Withdrawal Syndrome

Benzodiazepines are the gold standard treatment for alcohol withdrawal syndrome (AWS), with long-acting benzodiazepines like diazepam being preferred for most patients due to their rapid onset and self-tapering properties. 1

Initial Assessment and Treatment Setting

Severity Assessment

  • Use Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar) scale to assess severity:
    • Score >8: Moderate AWS
    • Score ≥15: Severe AWS 1

Treatment Setting Decision

  • Outpatient management is appropriate for:

    • Mild to moderate withdrawal without complications
    • No history of seizures or delirium tremens
    • Adequate social support 1, 2
  • Inpatient management is required for:

    • Severe AWS with complications (delirium, seizures)
    • History of withdrawal seizures or delirium tremens
    • Significant comorbidities (psychiatric or physical)
    • Inadequate social support
    • Failed outpatient treatment 1

Pharmacological Treatment

First-Line Therapy: Benzodiazepines

For Most Patients:

  • Diazepam (preferred): 10 mg PO 3-4 times during first 24 hours, then reducing to 5 mg 3-4 times daily as needed 3
    • Advantages: Rapid onset, long half-life providing smoother withdrawal 4
    • Dosing: Symptom-triggered approach preferred over fixed schedule 5

For Special Populations:

  • Lorazepam: 1-4 mg PO/IV/IM every 4-8 hours 1
    • Preferred for patients with:
      • Severe AWS
      • Advanced age
      • Recent head trauma
      • Liver failure
      • Respiratory failure
      • Obesity 1
    • Starting dose: 6-12 mg/day, tapered following symptom resolution 1

Adjunctive Therapies:

  • Thiamine: 100-300 mg/day for all AWS patients

    • Continue for 2-3 months after withdrawal resolution
    • Must be given before administering IV glucose to prevent Wernicke encephalopathy 1
    • Higher doses (100-500 mg/day) for patients with suspected Wernicke encephalopathy 1
  • Carbamazepine: 200 mg PO every 6-8 hours

    • Alternative to benzodiazepines for seizure prevention 1
    • Can be used for mild symptoms 2
  • Gabapentin: Alternative for mild symptoms or as adjunct therapy 2

  • Haloperidol: 0.5-5 mg PO/IM every 8-12 hours

    • Only as adjunctive therapy for agitation or psychotic symptoms not controlled by benzodiazepines
    • Not recommended as standalone treatment (increases seizure risk) 1, 6

Supportive Care:

  • Fluid and electrolyte replacement (especially magnesium)
  • Comfortable environment
  • Close monitoring of vital signs 1

Treatment Duration and Monitoring

  • Monitor patients daily for up to 5 days after last drink 2
  • Taper benzodiazepines gradually to prevent withdrawal reactions 3
  • Limit benzodiazepine treatment to 7-14 days to prevent dependence 1, 6

Common Pitfalls to Avoid

  1. Using CIWA protocol for diagnosis: The CIWA is for severity assessment and treatment planning, not for diagnosis of AWS 1

  2. Using antipsychotics as primary treatment: These increase seizure risk and should only be used as adjuncts to benzodiazepines 1, 6

  3. Failing to provide thiamine: Must be given before glucose administration to prevent precipitating acute thiamine deficiency 1

  4. Inadequate benzodiazepine dosing: Undertreating can lead to progression to seizures and delirium tremens 7

  5. Prolonged benzodiazepine use: Should be limited to 7-14 days to prevent dependence 1

Long-Term Management

After acute withdrawal management, consider:

  • Psychiatric consultation for evaluation and long-term abstinence planning 1
  • Medications to maintain abstinence (acamprosate, naltrexone, disulfiram) 1
  • Psychosocial support and referral to mutual help groups like Alcoholics Anonymous 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Alcohol Withdrawal Syndrome: Outpatient Management.

American family physician, 2021

Research

Alcohol withdrawal.

Southern medical journal, 2012

Research

Treatment of Severe Alcohol Withdrawal.

The Annals of pharmacotherapy, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.